A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children

PHASE3CompletedINTERVENTIONAL
Enrollment

543

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

GC3110A

A single 0.5mL dose intramuscular injection

BIOLOGICAL

GCFLU Pre-filled Syringe inj.

A single 0.5mL dose intramuscular injection

Trial Locations (12)

Unknown

Changwon Fatima Hospital, Changwon

Keimyung University Dongsan Medical Center, Daegu

The Catholic Univ. of Korea Daejeon St. Mary's Hospital, Daejeon

Chonnam National University Hospital, Gwangju

Inha University Hospital, Incheon

Chonbuk National University Hospital, Jeonju

Eulji University Medical Center, Seoul

Kepco Medical Center, Seoul

Korea Cancer Center Hospital, Seoul

The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul

The Catholic Univ. of Korea St. Vincent's Hospital, Suwon

Wonju Severance Christian Hospital, Wŏnju

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY

NCT02541253 - A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children | Biotech Hunter | Biotech Hunter